Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view).
Stryker Corp (SYK) is trading at $270.77, down 0.96% on the day. Its market value of $103.86B makes it the 152nd largest of the 300 companies we follow.
It is close to the bottom of its 52-week range ($267.00 to $389.48), 30.5% under the high. Holders are behind 26.3% over twelve months, and down 13.4% across the last three months.
On the chart it has slipped under both the 50-day ($317.41) and 200-day ($331.93) moving averages; RSI is 31, and the last 30 sessions moved at roughly 35% annualized volatility.
Revenue for the quarter ended Jun 2026 was $6.59B, up 9.4% from a year earlier, with $1.28B of net profit (a 14.4% margin).
Valuation works out to 28.1 times trailing earnings, 35% below its five-year average of 43.3. The median for its industry group is 23.8.
16 analysts follow the stock and the average call is "buy". The mean target, $372.40, sits 37.5% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Stryker makes joint replacement implants, the Mako surgical robot, and surgical and neurotechnology equipment.
What tends to move it. Elective procedure volumes and Mako robot adoption drive growth.
Written by hand by the BeStock desk and revised when a business changes. See how we work. Spot something out of date? Tell us.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -7.8% | Bearish |
| Price vs 50-day average | -14.7% | Bearish |
| Price vs 200-day average | -18.4% | Bearish |
| 50-day vs 200-day | 50d below 200d | Bearish |
| RSI (14) | 31.0 | Bearish |
| MACD (12,26,9) | -13.79 | Bearish |
| Bollinger band position | 24% | Bearish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Sep 24, 2026 1:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 300 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A row is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 0th percentile, 5-year average 43.3x
#2037 of 2974 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 0th percentile, 5-year average 6.3x
#4137 of 5302 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 1st percentile, 5-year average 5.7x
#3598 of 5139 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: −$161.94M (5 inflow days, 15 outflow days).
Across the full calendar years shown, the annual payout grew by roughly 8.4% a year.
$270.77 is the latest print for SYK, a move of -0.96% against yesterday's close of $273.40. Today's low and high so far: $270.39 and $275.71.
Equity value comes to $103.86B at the current price. By that measure it is number 152 of the 300 names in our coverage.
Buyers pay 28.1 times the last twelve months of profit (EPS $8.40). Averaged over five years the multiple has been 43.3, and today's level ranks in the 0th percentile of its own history.
The year's floor is $267.00 and the ceiling $389.48. Shares are 30.5% away from that ceiling.
It does. Payouts over the past twelve months work out to a 1.29% yield; the latest ex-dividend date was June 30, 2026.
Of 16 analysts, 94% say buy, 6% hold and 0% sell. Price targets average $372.40, with the most cautious at $317.00 and the most optimistic at $420.00.
Stryker makes joint replacement implants, the Mako surgical robot, and surgical and neurotechnology equipment.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.